Total Payments
$898.15
2024 Payments
$399.39
Companies
13
Transactions
44
Medicare Patients
588
Medicare Billing
$64,577
Payment Breakdown by Category
Food & Beverage$898.15 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $898.15 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $194.20 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $183.27 | 10 | $0 (2024) |
| CSL Behring | $120.87 | 6 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $114.71 | 1 | $0 (2021) |
| Biogen, Inc. | $52.78 | 3 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $48.33 | 3 | $0 (2024) |
| Grifols USA, LLC | $43.59 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $32.38 | 2 | $0 (2023) |
| Neurelis, Inc. | $29.96 | 2 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $25.07 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $399.39 | 21 | Teva Pharmaceuticals USA, Inc. ($117.82) |
| 2023 | $312.09 | 18 | UCB, Inc. ($61.15) |
| 2022 | $57.54 | 3 | Grifols USA, LLC ($22.27) |
| 2021 | $114.71 | 1 | ACADIA Pharmaceuticals Inc ($114.71) |
| 2019 | $14.42 | 1 | EISAI INC. ($14.42) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Central Nervous System | ||||||
| 09/19/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Neurology | ||||||
| 08/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Central Nervous System | ||||||
| 07/19/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Immunology | ||||||
| 07/19/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROLOGY | ||||||
| 06/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Central Nervous System | ||||||
| 06/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Immunology | ||||||
| 04/18/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Neurology | ||||||
| 04/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Neurology | ||||||
| 03/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Central Nervous System | ||||||
| 03/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Neurology | ||||||
| 03/07/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Neurology | ||||||
| 03/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Immunology | ||||||
| 02/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Central Nervous System | ||||||
| 02/22/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Neurology | ||||||
| 01/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Central Nervous System | ||||||
| 01/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Neurology | ||||||
| 12/14/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Immunology | ||||||
| 11/16/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Neurology | ||||||
| 11/16/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: EPILEPSY | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 272 | 363 | $94,385 | $31,032 |
| 2022 | 7 | 241 | 338 | $83,065 | $25,211 |
| 2021 | 4 | 75 | 95 | $24,683 | $8,334 |
Total Patients
588
Total Services
796
Medicare Billing
$64,577
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 85 | 104 | $30,399 | $10,689 | 35.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 46 | 46 | $21,038 | $5,501 | 26.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 48 | $11,043 | $4,394 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 58 | $8,958 | $3,520 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 41 | $8,834 | $3,044 | 34.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $9,989 | $2,944 | 29.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 27 | 44 | $4,124 | $939.30 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 58 | 66 | $20,886 | $6,982 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 39 | 39 | $18,291 | $4,808 | 26.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 87 | $13,707 | $4,627 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 52 | 62 | $14,607 | $4,458 | 30.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 23 | $5,313 | $1,698 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $5,695 | $1,547 | 27.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 28 | 46 | $4,566 | $1,089 | 23.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 24 | 24 | $10,440 | $3,413 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 27 | $6,075 | $2,071 | 34.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 26 | $4,082 | $1,428 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 18 | $4,086 | $1,421 | 34.8% |
About Dr. Tarek Ali, MBBS
Dr. Tarek Ali, MBBS is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1952857682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tarek Ali, MBBS has received a total of $898.15 in payments from pharmaceutical and medical device companies, with $399.39 received in 2024. These payments were reported across 44 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($898.15).
As a Medicare-enrolled provider, Ali has provided services to 588 Medicare beneficiaries, totaling 796 services with total Medicare billing of $64,577. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Lexington, KY
- Active Since 09/01/2016
- Last Updated 05/02/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1952857682
Products in Payments
- Briviact (Drug) $170.90
- Austedo XR (Drug) $166.73
- Hizentra (Biological) $120.87
- NUPLAZID (Drug) $114.71
- EPIDIOLEX (Drug) $48.33
- Gamunex-C (Biological) $43.59
- SKYCLARYS (Drug) $37.88
- NUEDEXTA (Drug) $32.38
- VALTOCO (Drug) $29.96
- REXULTI (Drug) $25.07
- FYCOMPA (Drug) $23.92
- Rystiggo (Drug) $23.30
- AUSTEDO (Drug) $16.54
- Skyclarys (Drug) $14.90
- COMIRNATY (Biological) $14.65
- Fycompa (Drug) $14.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Neurology $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Neurology $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Neurology $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Neurology $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Neurology $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615
Neurology $19,615